RenovoRx, Inc.

Develops a device platform for delivering targeted therapies directly to solid tumors.

RNXT | NDAQ

Overview

Corporate Details

ISIN(s):: US75989R1077
LEI:
Country:: United States of America
Address:: 2570 W. EL CAMINO REAL, STE. 320,, 94040 MOUNTAIN VIEW
Website:: https://renovorx.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

RenovoRx, Inc. is a clinical-stage life sciences company developing targeted therapies for solid tumor cancers. The company's proprietary Trans-Arterial Micro-Perfusion (TAMP™) platform utilizes its FDA-cleared RenovoCath® medical device to deliver therapeutic agents directly to the tumor site. This novel approach is designed to increase treatment efficacy and enhance patient safety by potentially minimizing the systemic toxicities associated with standard intravenous chemotherapy. RenovoRx's lead drug-device combination candidate is under evaluation in a pivotal Phase III clinical trial for locally advanced pancreatic cancer. Alongside its therapeutic development, the company is commercializing the RenovoCath device for targeted fluid delivery in the peripheral vascular system.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all RenovoRx, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RenovoRx, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for RenovoRx, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Envista Holdings Corp A global provider of comprehensive dental products, from implants and aligners to equipment.	United States of America	NVST
enVVeno Medical Corp Develops bioprosthetic venous valves for treating severe Chronic Venous Insufficiency.	United States of America	NVNO
Episurf Develops patient-specific orthopedic implants and surgical tools for joint degeneration.	Sweden	EPIS
Epitomee Medical Ltd. Develops ingestible therapeutic devices for weight management and targeted drug delivery.	Israel	EPIT
EssilorLuxottica Global leader in designing, manufacturing & distributing ophthalmic lenses, frames & sunglasses.	France	EL
ESTABLISHMENT LABS HOLDINGS INC. A medical tech company developing science-based Femtech solutions for breast aesthetics & reconstruction.	United States of America	ESTA
Etropal AD Manufactures disposable medical products, specializing in hemodialysis equipment and consumables.	Bulgaria	ETR
Euromedis Groupe Manufactures & distributes medical devices and provides home healthcare for facilities & patients.	France	ALEMG
EXAGEN INC. Provides advanced biomarker tests for diagnosing and monitoring chronic autoimmune diseases.	United States of America	XGN
FEMASYS INC Develops minimally invasive gynecological solutions for diagnostics, fertility, and birth control.	United States of America	FEMY